心包炎作为隐匿性癌症标志物及癌症死亡预后因素
心包炎后3个月内癌症风险2.7%,标准化发病率比12.4;后续降至1.5和1.1。合并心包炎的癌症患者3个月生存率80%对86%,死亡风险比1.5。
要点
- 急性心包炎后3个月内癌症风险为2.7%,标准化发病率比高达12.4。
- 心包炎后3至12个月癌症标准化发病率比降至1.5,之后接近人群水平。
- 合并心包炎的癌症患者3个月生存率80%对86%,死亡风险比1.5。
核心结论
- 心包炎可能是隐匿性癌症的标志,并预示癌症诊断后死亡率增加。
研究设计与样本
- 采用标准化发病率比与一般人群比较癌症风险,用Kaplan-Meier法和Cox回归分析癌症生存。
主要发现
- 总体癌症标准化发病率比为1.5(95%CI 1.4-1.5),以肺癌、肾癌、膀胱癌、淋巴瘤、白血病及未特指转移癌增加为主。
- 心包炎后<3个月癌症风险2.7%,标准化发病率比12.4(95%CI 11.2-13.7)。
- 心包炎后3至<12个月癌症标准化发病率比1.5(95%CI 1.2-1.7),随后降至1.1(95%CI 1.0-1.2)。
- 癌症诊断后3个月生存率:有心包炎者80%,无心包炎者86%,风险比1.5(95%CI 1.3-1.8)。
临床怎么用
- 对急性心包炎患者,尤其随访早期,应警惕隐匿性癌症可能并进行相应筛查评估。
- 合并心包炎的癌症患者预后较差,需加强生存管理与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pericarditis may be a serious complication of malignancy. Its significance as a first symptom of occult cancer and as a prognostic factor for cancer survival is unknown. METHODS: Using Danish medical databases, we conducted a nationwide cohort study of all patients with a first-time diagnosis of pericarditis during 1994 to 2013. We excluded patients with previous cancer and followed up the remaining patients for subsequent cancer diagnosis until November 30, 2013. We calculated risks and standardized incidence ratios of cancer for patients with pericarditis compared with the general population. We assessed whether pericarditis predicts cancer survival by the Kaplan-Meier method and Cox regression using a matched comparison cohort of cancer patients without pericarditis. RESULTS: Among 13 759 patients with acute pericarditis, 1550 subsequently were diagnosed with cancer during follow-up. The overall cancer standardized incidence ratio was 1.5 (95% confidence interval [CI], 1.4-1.5), driven predominantly by increased rates of lung, kidney, and bladder cancer, lymphoma, leukemia, and unspecified metastatic cancer. The <3-month cancer risk among patients with pericarditis was 2.7%, and the standardized incidence ratio was 12.4 (95% CI, 11.2-13.7). The 3- to <12-month standardized incidence ratio of cancer was 1.5 (95% CI, 1.2-1.7), subsequently decreasing to 1.1 (95% CI, 1.0-1.2). Three-month survival after the cancer diagnosis was 80% and 86% among those with and without pericarditis, respectively, and the hazard ratio was 1.5 (95% CI, 1.3-1.8). One-year survival was 65% and 70%, respectively, corresponding to a 3- to <12-month hazard ratio of 1.3 (95% CI, 1.1-1.5). CONCLUSIONS: Pericarditis may be a marker of occult cancer and augurs increased mortality after a cancer diagnosis.
引用
- Søgaard KK, Farkas DK, Ehrenstein V, et al. Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality. Circulation. 2017. PMID: 28663234. doi:10.1161/CIRCULATIONAHA.116.024041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。